Walmart Signs Contract With Canoo To Revolutionize Home Delivery: How The Retail Giant Plans On Beating Amazon
The world’s largest retailer Walmart, Inc. (NYSE: WMT) has committed to purchasing 4,500 Canoo, Inc.
Exclusive: AMC Ape Matt Kohrs Says, ‘Short Term, My Prediction Is Just Crazy Volatility’
Matt Kohrs, a popular YouTube personality among the retail investor crowd that “diamond-hands” shares of GameStop Corp. (NYSE: GME) and AMC Entertainment Holdings Inc (NYSE: AMC) appeared Tue
Chart Wars: A Look At American Airlines, Southwest After The Airline Stocks Confirm Reversal
American Airlines Group, Inc (NASDAQ: AAL) and Southwest Airlines Company (NYSE: LUV) rallied Tuesday after completing a period of consolidation that took place between July 6 and Monday.
Vaxcyte Concludes Enrolment In Mid-Stage Pneumococcal Disease Study
Vaxcyte (NASDAQ: PCVX) completed patient enrollment in the Phase 2 portion of the ongoing Phase 1/2 proof-of-concept study evaluating VAX-24 in healthy adults 50 to 64 years of age.
Exclusive: Louis Navellier Says PepsiCo ‘Raising Guidance Helped The Entire Market’
Benzinga's Money Mitch had the opportunity to catch up with Navellier & Associates founder and Chief Investment Officer Louis Navellier on Benzinga’s Stock Market Movers today. Navellier, who is routinely on Bloomberg, Fox News and CNBC, was on to spea
Atara Biotherapeutics Announces Completion Of The ATA188 Phase 2 EMBOLD Study Interim Analysis In Patients With Progressive MS
Independent Data and Safety Monitoring Committee Recommends Continuing Study Without Sample Size Adjustment
IDSMC Did Not Identify Any Safety Concerns
Phase 2 Study Target Enrollment Achieved; Final Data
Renovacor Announces New Research Program For Multiple Genetic Segments Of Arrhythmogenic Cardiomyopathy
Research collaboration with the University of Utah's Nora Eccles Harrison Cardiovascular Research and Training Institute expands pipeline with the addition of an AAV gene therapy program for multiple genetic segments
Invest In The Future Of Medicine Says Berner, CEO Of Cookies At Benzinga’s Psychedelics Capital Conference
Berner, the famed rapper, co-founder and CEO of the highly successful cannabis and clothing brand, Cookies, was one of the main speakers at Benzinga's Psychedelics Capital Conference last April at the Fontainebleau Miami Beach Hotel.
Avidity Biosciences Or Dyne Therapeutics – Read On Raymond James’ Rating Skew
Raymond James initiated coverage on Avidity Biosciences Inc (NASDAQ:RNA) with a Strong Buy rating and $29 price target (68% upside) and Dyne Therapeutics Inc (NASDAQ:DYN)…
HC Wainwright Sees Agile Therapeutics’ Twirla Tailwinds Post Roe-Wade Ruling
Agile Therapeutics Inc's (NASDAQ: AGRX) Twirla, the only low-dose transdermal hormonal contraceptive, should have tailwinds protected after the Supreme Court overturned Roe vs. Wade ruling that legalized abortion nationwide.